A NOVEL MGB PROBE-BASED ASSESSMENT OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CARRYING NPM1 (NUCLEOPHOSMIN) EXON 12 MUTATIONS

被引：0
|
作者：
Dvorakova, D. [1 ]
Ohlidalova, D. [1 ]
Pospisilova, J. [1 ]
Lengerova, M. [1 ]
Mayer, J. [1 ]
机构：
[1] Univ Hosp Brno, Brno, Czech Republic
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0560
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [11] Assessment of prognosis and minimal residual disease in acute myeloid leukemia based on the use of NPM1 gene mutations in patients of Gomel Region, Belarus
    Kozich, Z.
    Silin, A.
    Martinkov, V
    Tropashko, I
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 47 - 48
  • [12] EVALUATION OF MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA WITH NPM1 MARKER
    Alizadghandforoush, N.
    Nadali, F.
    Rostami, S.
    Chahardouli, B.
    Ghadimi, H.
    Ghasemi, A.
    Alimoghaddam, K.
    Ghavamzadeh, A.
    HAEMATOLOGICA, 2015, 100 : 657 - 658
  • [13] Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
    Mencia-Trinchant, Nuria
    Hu, Yang
    Alas, Maria Antonina
    Ali, Fatima
    Wouters, Bas J.
    Lee, Sangmin
    Ritchie, Ellen K.
    Desai, Pinkal
    Guzman, Monica L.
    Roboz, Gail J.
    Hassane, Duane C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (04): : 537 - 548
  • [14] NOVEL MUTATIONS AND TRANSLOCATIONS INVOLVING NUCLEOPHOSMIN (NPM1) GENE IN ACUTE MYELOID LEUKEMIA (AML) AND LEADING TO ABERRANT CYTOPLASMIC NPM1
    Martelli, M. P.
    Rossi, R.
    Venanzi, A.
    Meggendorfer, M.
    Perriello, V.
    Spinelli, O.
    Ciurnelli, R.
    Brunetti, L.
    Ascani, S.
    Quadalti, C.
    Specchia, G.
    Di Raimondo, F.
    Avvisati, G.
    Rambaldi, A.
    Falzetti, F.
    Tiacci, E.
    Sportoletti, P.
    Haferlach, T.
    Haferlach, C.
    Falini, B.
    HAEMATOLOGICA, 2018, 103 : S18 - S19
  • [15] Prognostic Impact of Nucleophosmin 1 (NPM1) Gene Mutations in Egyptian Acute Myeloid Leukemia Patients
    Zidan, Magda
    Shaaban, Howyda
    El Ghannam, Doaa
    TURKISH JOURNAL OF HEMATOLOGY, 2013, 30 (02) : 129 - 136
  • [16] Minimal residual disease detection in acute myeloid leukemia (AML) by mutant nucleophosmin (NPM1) early predicts impending relapse
    Shayegi, N.
    Kramer, M.
    Bornhaeuser, M.
    Schaich, M.
    Schetelig, J.
    Platzbecker, U.
    Roellig, C.
    Ehninger, G.
    Thiede, C.
    ONKOLOGIE, 2011, 34 : 298 - 298
  • [17] Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1):: Comparison with WT1 gene expression
    Barragan, Eva
    Pajuelo, Juan C.
    Ballester, Sandra
    Fuster, Oscar
    Cervera, Jose
    Moscardo, Federico
    Senent, Leonor
    Such, Esperanza
    Sanz, Miguel A.
    Bolufer, Pascual
    CLINICA CHIMICA ACTA, 2008, 395 (1-2) : 120 - 123
  • [18] Mutant NPM1 is a Reliable marker of Minimal Residual leukemia in patients with Acute Myeloid Leukemia
    Jain, Preetesh
    Kantarjian, Hagop M.
    Faderl, Stefan
    Patel, Keyur P.
    Manero, Guillermo Garcia
    Benjamini, Ohad
    Borthakur, Gautam
    Pemmaraju, Naveen
    Kadia, Tapan M.
    Daver, Naval G.
    Nazha, Aziz
    Luthra, Rajyalakshmi
    Pierce, Sherry A.
    Cortes, Jorge E.
    Ravandi, Farhad
    BLOOD, 2012, 120 (21)
  • [19] Rapid detection of nucleophosmin (NPM1) mutations in acute myeloid leukemia by denaturing HPLC
    Ammatuna, E
    Noguera, NI
    Zangrilli, D
    Curzi, P
    Panetta, P
    Bencivenga, P
    Amadori, S
    Federici, G
    Lo-Coco, F
    CLINICAL CHEMISTRY, 2005, 51 (11) : 2165 - 2167
  • [20] VALIDATION OF RAPID MUTATION SCANNING FOR NUCLEOPHOSMIN (NPM1) MUTATIONS IN ACUTE MYELOID LEUKEMIA
    Leibundgut, E. Oppliger
    Porret, N.
    Muggli, M. Bienz
    Pfanner-Meyer, B.
    Baerlocher, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 673 - 674
12345